NCT06485323

Brief Summary

It is possible to perform a pelvimetry by MRI as a substitute to pelvimetry by CT, hence sparing the patient from a dose of irradiation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jul 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Jul 2023Dec 2026

Study Start

First participant enrolled

July 5, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 3, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

3.5 years

First QC Date

May 27, 2024

Last Update Submit

April 23, 2026

Conditions

Keywords

technological progress

Outcome Measures

Primary Outcomes (1)

  • Prove the non-inferiority of MRI compared to CT for pelvimetry.

    Measurement of pelvic bone diameters in pregnant women

    30 minutes (duration of the exam+ measurement)

Secondary Outcomes (1)

  • Evaluate patient convenience for both examinations (CT and MRI)

    immediately after both examinations

Study Arms (1)

IRM + CT scan for Pelvimetry

EXPERIMENTAL
Device: MRI pelvimetry

Interventions

MRI of the pelvis

IRM + CT scan for Pelvimetry

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailshaving an uterus
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant woman 33 to 41 week
  • Woman who gave birth by cesarean section, for whom the obstetrician requests a pelvimetry CT for the next pregnancy
  • Pelvimetry planned by the obstetrical team outside of "emergency" pathway
  • Adhere to the study protocol after reading the patient information document have signed the informed consent form to participate in the study

You may not qualify if:

  • Usual contraindications to MRI (Pacemaker, Metallic foreign body, Cochlear implant,…)
  • Severe claustrophobia
  • uncomfortable back position

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universaires Siant Luc

Brussels, 1200, Belgium

RECRUITING

Related Publications (3)

  • Hampel F, Hallscheidt P, Sohn C, Schlehe B, Brocker KA. Pelvimetry in nulliparous and primiparous women using 3 Tesla magnetic resonance imaging. Neurourol Urodyn. 2018 Aug;37(6):1950-1956. doi: 10.1002/nau.23537. Epub 2018 Feb 21.

    PMID: 29464757BACKGROUND
  • Li J, Lou Y, Chen C, Zheng W, Chen Y, Dong T, Yang M, Zhao B, Luo Q. Predictive Value of MRI Pelvimetry in Vaginal Delivery and Its Practicability in Prolonged Labour-A Prospective Cohort Study. J Clin Med. 2023 Jan 5;12(2):442. doi: 10.3390/jcm12020442.

    PMID: 36675370BACKGROUND
  • Liao KD, Yu YH, Li YG, Chen L, Peng C, Liu P, Chen CL, Chen RY, Zhong M, Wang Y. Three-dimensional magnetic resonance pelvimetry: A new technique for evaluating the female pelvis in pregnancy. Eur J Radiol. 2018 May;102:208-212. doi: 10.1016/j.ejrad.2018.03.024. Epub 2018 Mar 19.

    PMID: 29685537BACKGROUND

MeSH Terms

Conditions

Obstetric Labor Complications

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Frédéric Lecouvet, MD, PhD

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Frédéric Lecouvet, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Each patients will have a CT scan (classic follow-up) and an MRI (for the study)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2024

First Posted

July 3, 2024

Study Start

July 5, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations